Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

Blueberry Therapeutics Ltd.. (4/8/15). "Press Release: Blueberry Raises $1.75M in Investment".

Organisation Organisation Blueberry Therapeutics Ltd.
Products Product nanotechnology drug delivery technology
  Product 2 venture capital
Index term Index term Blueberry Therapeutics–SEVERAL: investment, 201504 financing round $1.75m from UK + Swiss investors

Blueberry today announced the successful completion of an investment round raising a total of $1.75M from both UK and Swiss based investors. The investment will help take its 2 most advanced programs through to regulatory approval stage. Dr Mike Davies, Chief Medical Officer at Blueberry Therapeutics, commented that “this exciting investment now allows Blueberry to progress its most advanced nanotechnology program to clinical trial application (CTA) in EU and the second program, in onychomycosis, to IND stage in the USA before entering clinical trials early next year’.

Record changed: 2018-08-19


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Blueberry Therapeutics Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

» top